Showing 18 of 98 recruiting trials for “squamous-cell-carcinoma-of-the-stomach”
Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma
RecruitingNCT05392413 ↗
Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody
👨⚕️ Lei Zheng, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Aug 2022View details ↗
Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
👨⚕️ Xiaolin MM GE, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Jul 2022View details ↗
Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
👨⚕️ Song Zhao, The First Affiliated Hospital of Zhengzhou University📍 1 site📅 Started Jan 2022View details ↗
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
RecruitingNCT05740995 ↗
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
👨⚕️ Magnus Nilsson, MD, PhD, Karolinska University Hospital📍 12 sites📅 Started Nov 2020View details ↗
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
👨⚕️ Mary Feng, MD, University of California, San Francisco📍 2 sites📅 Started Aug 2020View details ↗
A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma
Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)
RecruitingNCT04522687 ↗
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
RecruitingNCT06476067 ↗
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
RecruitingNCT06490003 ↗
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
← PreviousPage 5 of 5
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →